TY - JOUR
T1 - Challenges of neuropathic pain
T2 - focus on diabetic neuropathy
AU - Rosenberger, Daniela C.
AU - Blechschmidt, Vivian
AU - Timmerman, Hans
AU - Wolff, Andre
AU - Treede, Rolf-Detlef
PY - 2020/4
Y1 - 2020/4
N2 - Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain is diabetic neuropathy. Its complex pathophysiology is not yet fully elucidated, which contributes to underassessment and undertreatment. A mechanism-based treatment of painful diabetic neuropathy is challenging but phenotype-based stratification might be a way to develop individualized therapeutic concepts. Our goal is to review current knowledge of the pathophysiology of peripheral neuropathic pain, particularly painful diabetic neuropathy. We discuss state-of-the-art clinical assessment, validity of diagnostic and screening tools, and recommendations for the management of diabetic neuropathic pain including approaches towards personalized pain management. We also propose a research agenda for translational research including patient stratification for clinical trials and improved preclinical models in relation to current knowledge of underlying mechanisms.
AB - Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain is diabetic neuropathy. Its complex pathophysiology is not yet fully elucidated, which contributes to underassessment and undertreatment. A mechanism-based treatment of painful diabetic neuropathy is challenging but phenotype-based stratification might be a way to develop individualized therapeutic concepts. Our goal is to review current knowledge of the pathophysiology of peripheral neuropathic pain, particularly painful diabetic neuropathy. We discuss state-of-the-art clinical assessment, validity of diagnostic and screening tools, and recommendations for the management of diabetic neuropathic pain including approaches towards personalized pain management. We also propose a research agenda for translational research including patient stratification for clinical trials and improved preclinical models in relation to current knowledge of underlying mechanisms.
KW - Painful diabetic neuropathy
KW - Spinal sensitization
KW - Neuroinflammation
KW - Quantitative sensory testing
KW - Stratification in clinical trials
KW - Personalized pain management
KW - PERIPHERAL-NERVE INJURY
KW - GATED SODIUM-CHANNELS
KW - ALPHA-LIPOIC ACID
KW - DIAGNOSE DISTAL POLYNEUROPATHY
KW - CONTROLLED-RELEASE OXYCODONE
KW - RANDOMIZED CONTROLLED-TRIAL
KW - GERMAN RESEARCH NETWORK
KW - HUMAN SURROGATE MODELS
KW - PROTEIN-KINASE-C
KW - DOUBLE-BLIND
U2 - 10.1007/s00702-020-02145-7
DO - 10.1007/s00702-020-02145-7
M3 - Review article
SN - 0300-9564
VL - 127
SP - 589
EP - 624
JO - Journal of Neural Transmission
JF - Journal of Neural Transmission
IS - 4
ER -